APTOF
Price
$2.20
Change
+$0.08 (+3.77%)
Updated
Apr 25 closing price
Capitalization
5.33M
LOGC
Price
$7.12
Change
-$0.17 (-2.33%)
Updated
Apr 28, 04:59 PM (EDT)
Capitalization
187.35M
Ad is loading...

APTOF vs LOGC

Header iconAPTOF vs LOGC Comparison
Open Charts APTOF vs LOGCBanner chart's image
Aptose Biosciences
Price$2.20
Change+$0.08 (+3.77%)
Volume$1.41K
Capitalization5.33M
ContextLogic
Price$7.12
Change-$0.17 (-2.33%)
Volume$7.21K
Capitalization187.35M
APTOF vs LOGC Comparison Chart
Loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTOF vs. LOGC commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTOF is a Hold and LOGC is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (APTOF: $2.20 vs. LOGC: $7.29)
Brand notoriety: APTOF and LOGC are both not notable
APTOF represents the Biotechnology, while LOGC is part of the Internet Retail industry
Current volume relative to the 65-day Moving Average: APTOF: 0% vs. LOGC: 98%
Market capitalization -- APTOF: $5.77M vs. LOGC: $187.35M
APTOF [@Biotechnology] is valued at $5.77M. LOGC’s [@Internet Retail] market capitalization is $187.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $272.64B to $0. The market cap for tickers in the [@Internet Retail] industry ranges from $1.99T to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B. The average market capitalization across the [@Internet Retail] industry is $38.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTOF’s FA Score shows that 0 FA rating(s) are green whileLOGC’s FA Score has 0 green FA rating(s).

  • APTOF’s FA Score: 0 green, 5 red.
  • LOGC’s FA Score: 0 green, 5 red.
According to our system of comparison, both APTOF and LOGC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTOF’s TA Score shows that 5 TA indicator(s) are bullish while LOGC’s TA Score has 4 bullish TA indicator(s).

  • APTOF’s TA Score: 5 bullish, 5 bearish.
  • LOGC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, APTOF is a better buy in the short-term than LOGC.

Price Growth

APTOF (@Biotechnology) experienced а +11.68% price change this week, while LOGC (@Internet Retail) price change was +8.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.19%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -9.09%.

The average weekly price growth across all stocks in the @Internet Retail industry was +3.46%. For the same industry, the average monthly price growth was +108.95%, and the average quarterly price growth was +34.03%.

Reported Earning Dates

APTOF is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (+11.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Internet Retail (+3.46% weekly)

The internet retail industry includes companies that sell products and services through the Internet. With more and more consumers using online retailers, the companies have seen a big increase in the use of their services. Some of the companies in the group are focused on selling business-to-business products and services. Others sell business-to-consumer products and services. Internet retailers offer a wide variety of products like books, apparel, and electronics. Some companies even specialize in only one or two categories. One potentially critical factor for players to thrive in this space is the quality and speed of product delivery. This requires an investment in efficient distribution networks. Things like logistics are important factors in the success in the extremely competitive industry. For a company to stay relevant in the industry it must have effective pricing strategies and upgraded websites. The websites must be easy to navigate and engaging for customers. In addition to the revenues generated from straight sales, internet retailers can generate revenue from subscription fees and advertising. Amazon.com, Inc., Alibaba Group, and JD.com are some of the global leaders.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LOGC($187M) has a higher market cap than APTOF($5.33M). APTOF YTD gains are higher at: 876.476 vs. LOGC (3.698). APTOF has higher annual earnings (EBITDA): -24.82M vs. LOGC (-78M). LOGC has more cash in the bank: 149M vs. APTOF (3.32M). LOGC has less debt than APTOF: LOGC (0) vs APTOF (10.7M). LOGC has higher revenues than APTOF: LOGC (43M) vs APTOF (0).
APTOFLOGCAPTOF / LOGC
Capitalization5.33M187M3%
EBITDA-24.82M-78M32%
Gain YTD876.4763.69823,699%
P/E RatioN/AN/A-
Revenue043M-
Total Cash3.32M149M2%
Total Debt10.7M0-
FUNDAMENTALS RATINGS
APTOF vs LOGC: Fundamental Ratings
APTOF
LOGC
OUTLOOK RATING
1..100
5033
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
10099
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
3445
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APTOF's Valuation (50) in the Biotechnology industry is in the same range as LOGC (50) in the Pharmaceuticals Major industry. This means that APTOF’s stock grew similarly to LOGC’s over the last 12 months.

LOGC's Profit vs Risk Rating (99) in the Pharmaceuticals Major industry is in the same range as APTOF (100) in the Biotechnology industry. This means that LOGC’s stock grew similarly to APTOF’s over the last 12 months.

LOGC's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as APTOF (99) in the Biotechnology industry. This means that LOGC’s stock grew similarly to APTOF’s over the last 12 months.

APTOF's Price Growth Rating (34) in the Biotechnology industry is in the same range as LOGC (45) in the Pharmaceuticals Major industry. This means that APTOF’s stock grew similarly to LOGC’s over the last 12 months.

APTOF's P/E Growth Rating (100) in the Biotechnology industry is in the same range as LOGC (100) in the Pharmaceuticals Major industry. This means that APTOF’s stock grew similarly to LOGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOFLOGC
RSI
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 4 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
77%
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LOGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MDFOX7.020.11
+1.59%
BlackRock Large Cap Focus Growth Inv A
SEEFX18.950.14
+0.74%
Saturna Sustainable Equity
FIQBX27.010.12
+0.45%
Fidelity Advisor Asset Manager 70% Z
POIRX15.58-0.01
-0.06%
Polen International Growth Investor
KSOAX179.33-0.16
-0.09%
Kinetics Small Cap Opportunities Adv A

APTOF and

Correlation & Price change

A.I.dvisor tells us that APTOF and BDTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTOF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTOF
1D Price
Change %
APTOF100%
+3.77%
BDTX - APTOF
30%
Poorly correlated
-1.24%
LOGC - APTOF
28%
Poorly correlated
+2.68%
MDGL - APTOF
28%
Poorly correlated
+2.14%
SLNO - APTOF
28%
Poorly correlated
-1.31%
HUMA - APTOF
27%
Poorly correlated
-2.70%
More